COMMENTARY

Warning Flags for Erythropoiesis-Stimulating Agents and Cancer-Associated Anemia

Terence R. Lappin, A. Peter Maxwell, Patrick G. Johnston
The Oncologist 2007; 12: 362-365; doi:10.1634/theoncologist.12-4-362
[Full Text] [PDF]  

Health and Health Care for the 21st Century: For All the People

C. Everett Koop
The Oncologist 2007; 12: 366-369; doi:10.1634/theoncologist.12-4-366
[Full Text] [PDF]  

Steroid Sulfatase: A New Target for the Endocrine Therapy of Breast Cancer

Susannah J. Stanway, Patrick Delavault, Atul Purohit, L. W. Lawrence Woo, Christophe Thurieau, Barry V. L. Potter, Michael J. Reed
The Oncologist 2007; 12: 370-374; doi:10.1634/theoncologist.12-4-370
[Abstract] [Full Text] [PDF]  

Capecitabine in Combination with Novel Targeted Agents in the Management of Metastatic Breast Cancer: Underlying Rationale and Results of Clinical Trials

Debu Tripathy
The Oncologist 2007; 12: 375-389; doi:10.1634/theoncologist.12-4-375
[Abstract] [Full Text] [PDF]  

Achieving Higher Pathological Complete Response Rates in HER-2–Positive Patients With Induction Chemotherapy Without Trastuzumab in Operable Breast Cancer

Frédérique Penault-Llorca, Catherine Abrial, Marie-Ange Mouret-Reynier, Inès Raoelfils, Xavier Durando, Marianne Leheurteur, Pierre Gimbergues, Jacques Tortochaux, Hervé Curé, Philippe Chollet
The Oncologist 2007; 12: 390-396; doi:10.1634/theoncologist.12-4-390
[Abstract] [Full Text] [PDF]  

Pharmacodiagnostics and Targeted Therapies—A Rational Approach for Individualizing Medical Anticancer Therapy in Breast Cancer

Jan Trøst Jørgensen, Kirsten Vang Nielsen, Bent Ejlertsen
The Oncologist 2007; 12: 397-405; doi:10.1634/theoncologist.12-4-397
[Abstract] [Full Text] [PDF]  

BAC Clones Related to Prognosis in Patients with Esophageal Squamous Carcinoma: An Array Comparative Genomic Hybridization Study

Shigeo Hirasaki, Tsuyoshi Noguchi, Koshi Mimori, Junko Onuki, Keiko Morita, Hiroshi Inoue, Kenichi Sugihara, Masaki Mori, Takashi Hirano
The Oncologist 2007; 12: 406-417; doi:10.1634/theoncologist.12-4-406
[Abstract] [Full Text] [PDF] [Supplemental Data]  

Cancer of Unknown Primary Site: Missing Primary or Missing Biology?

George Pentheroudakis, Evangelos Briasoulis, Nicholas Pavlidis
The Oncologist 2007; 12: 418-425; doi:10.1634/theoncologist.12-4-418
[Abstract] [Full Text] [PDF]  

Safety, Pharmacokinetics, and Preliminary Antitumor Activity of Sorafenib: A Review of Four Phase I Trials in Patients with Advanced Refractory Solid Tumors

Dirk Strumberg, Jeffrey W. Clark, Ahmad Awada, Malcolm J. Moore, Heike Richly, Alain Hendlisz, Hal W. Hirte, Joseph P. Eder, Heinz-Josef Lenz, Brian Schwartz
The Oncologist 2007; 12: 426-437; doi:10.1634/theoncologist.12-4-426
[Abstract] [Full Text] [PDF]  

Disease Progression Following Imatinib Failure in Gastrointestinal Stromal Tumors: Role of Surgical Therapy

Faek R. Jamali, Sophie S. Darwiche, Nizar El-Kinge, Ayman Tawil, Assaad M. Soweid
The Oncologist 2007; 12: 438-442; doi:10.1634/theoncologist.12-4-438
[Abstract] [Full Text] [PDF]  

Target Practice: Lessons from Phase III Trials with Bevacizumab and Vatalanib in the Treatment of Advanced Colorectal Cancer

Maartje Los, Jeanine M. L. Roodhart, Emile E. Voest
The Oncologist 2007; 12: 443-450; doi:10.1634/theoncologist.12-4-443
[Abstract] [Full Text] [PDF]  

Sequential, Alternating, and Maintenance/Consolidation Chemotherapy in Advanced Non-Small Cell Lung Cancer: A Review of the Literature

Francesco Grossi, Marianna Aita, Alessandro Follador, Carlotta Defferrari, Annalisa Brianti, Graziella Sinaccio, Ornella Belvedere
The Oncologist 2007; 12: 451-464; doi:10.1634/theoncologist.12-4-451
[Abstract] [Full Text] [PDF]  

Design of Clinical Trials of Radiation Combined with Antiangiogenic Therapy

Suresh Senan, Egbert F. Smit
The Oncologist 2007; 12: 465-477; doi:10.1634/theoncologist.12-4-465
[Abstract] [Full Text] [PDF]  

Evaluating the Total Costs of Chemotherapy-Induced Febrile Neutropenia: Results from a Pilot Study with Community Oncology Cancer Patients

Charles L. Bennett, Elizabeth A. Calhoun
The Oncologist 2007; 12: 478-483; doi:10.1634/theoncologist.12-4-478
[Abstract] [Full Text] [PDF]  

Neutropenic Events in Community Practices Reduced by First and Subsequent Cycle Pegfilgrastim Use

Howard Ozer, Barry Mirtsching, Michael Rader, Susan Luedke, Stephen J. Noga, Beiying Ding, Lyndah Dreiling
The Oncologist 2007; 12: 484-494; doi:10.1634/theoncologist.12-4-484
[Abstract] [Full Text] [PDF]  

Assessing Responsiveness of Cancer-Related Fatigue Instruments: Distribution-Based and Individual Anchor-Based Methods

Shiow-Ching Shun, Susan L. Beck, Marjorie A. Pett, Stephanie J. Richardson
The Oncologist 2007; 12: 495-504; doi:10.1634/theoncologist.12-4-495
[Abstract] [Full Text] [PDF]  

To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button.